[HTML][HTML] Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis research & …, 2018 - Springer
Background Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
[PDF][PDF] Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore, L Czirják… - 2018 - zoraprod.uzh.ch
Background: Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis research & …, 2018 - boris.unibe.ch
BACKGROUND Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of
SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc for various …
SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc for various …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis Research & …, 2018 - zora.uzh.ch
BACKGROUND: Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of
SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc for various …
SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc for various …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, DA rte Huscher, E Siegert, Y Allanore… - Arthritis Research & …, 2018 - go.gale.com
Background Interstitial lung disease (ILD) in systemic sclerosis (SSc-ILD) is caused by
alveolitis-induced fibrosis of the intra-alveolar tissue, leading to progressive decline in lung …
alveolitis-induced fibrosis of the intra-alveolar tissue, leading to progressive decline in lung …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis Research & …, 2018 - europepmc.org
Background Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis research & …, 2018 - folia.unifr.ch
METHODS We analysed patients fulfilling American College of Rheumatology
(ACR)/European League against Rheumatism (EULAR) 2013 criteria for SSc-ILD and at …
(ACR)/European League against Rheumatism (EULAR) 2013 criteria for SSc-ILD and at …
[引用][C] Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis Research & …, 2018 - cir.nii.ac.jp
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive
therapy and course of lung function: results of the EUSTAR group | CiNii Research CiNii 国立 …
therapy and course of lung function: results of the EUSTAR group | CiNii Research CiNii 国立 …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: Results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore… - ARTHRITIS …, 2018 - iris.unicampania.it
Background: Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert… - Arthritis research …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …